Acquired Antithrombin III Deficiency

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Acquired Antithrombin III Deficiency trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 3

NCT06096116

Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Patients S…

The primary objective of this study is to evaluate the efficacy of two different doses of Atenativ, versus placebo, in restoring and maintaining heparin respons…

United States120 participantsStarted 2024-08-21

Treatment: Human plasma derived antithrombin, Placebo

All recent trials (3 shown)

CompletedPhase 2

NCT00823082

Use of Antithrombin in Cardiac Surgery With Cardiopulmonary Bypass

The purpose of this trial is to study the effects of preoperative antithrombin supplementation in patients undergoing cardiac surgery with cardiopulmonary bypas…

Italy200 participantsStarted 2009-06

Treatment: Antithrombin III

TerminatedPhase 4

NCT01547728

Response of Recombinant Antithrombin in Heparin Resistant Patients Undergoing Cardiac Surgery

The objective of this study is to prospectively evaluate the response of recombinant antithrombin (rAT) (ATRYN) in patients who are heparin resistant and are sc…

United States42 participantsStarted 2012-02

Treatment: Recombinant antithrombin (rhAT)